Psychemedics Corp는 주당 0.00의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 분기별에 지급되며, 마지막 배당금 지급일은 May 24, 2023였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.00
May 24, 2023
지급 빈도
지급 비율
분기별
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
May 24, 2023
$0.07
May 25, 2023
Jun 8, 2023
Mar 30, 2023
$0.07
Mar 31, 2023
Apr 10, 2023
Dec 1, 2022
$0.07
Dec 2, 2022
Dec 16, 2022
Aug 23, 2022
$0.07
Aug 24, 2022
Sep 9, 2022
May 26, 2022
$0.07
May 27, 2022
Jun 24, 2022
Dec 17, 2021
$0.05
Dec 20, 2021
Dec 30, 2021
배당금 차트
PMDI 배당금
PMDI 배당금 성장률(년간 비교)
Follow-Up Questions
Psychemedics Corp의 현재 배당금과 연간 배당금은 얼마인가요?
Psychemedics Corp이 현재 지급하는 배당금은 $0.07입니다. Psychemedics Corp의 연간 배당금은 $0.00입니다.
Psychemedics Corp의 배당 성향은 얼마인가요?
Psychemedics Corp의 배당 성향은 0.00%입니다.
PMDI의 배당락일은 언제인가요?
Psychemedics Corp의 배당락일은 May 24, 2023입니다.
Psychemedics Corp은 얼마나 자주 배당금을 지급하나요?
분기별. Psychemedics Corp이 마지막으로 배당금을 지급한 날짜는 Jun 8, 2023입니다.
주요 통계
이전 종가
$1.38
시가
$1.4
일일 범위
$1.4 - $1.48
52주 범위
$1.37 - $2.4
거래량
68.2K
평균 거래량
3.2K
배당수익률
0.00%
EPS(TTM)
-0.32
시가총액
$9.0M
PMDI란 무엇인가요?
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 101 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.